Salarius raises ~$1.5M to meet Nasdaq minimum equity requirement after being below $2.5M threshold

Decoy Therapeutics Inc.

As of June 30, 2024, stockholders' equity was $2,375,353, below Nasdaq's $2.5M minimum.
Sold 564,730 shares for gross proceeds of ~$1.5M via at-the-market offering to restore compliance.
Company believes it now complies with Nasdaq Listing Rule 5550(b)(1) after the financing.
Nasdaq will monitor; if next 10-Q shows non-compliance, common stock may be delisted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.